UltraSight Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $23.9M

  • Investors
  • 22

UltraSight General Information

Description

Operator of an artificial intelligence-powered cardiac ultrasound system intended to improve the quality and accessibility of cardiac care. The company's technology guides ultrasound operators, helping them to acquire quality images more quickly and easily, which can lead to earlier diagnosis and treatment of heart disease, enabling medical professionals to acquire timely and accurate cardiac ultrasound images anywhere.

Contact Information

Website
www.ultrasight.com
Formerly Known As
On-Sight Medical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • One Broadway, 14th Floor
  • Cambridge, MA 02142
  • United States
Primary Industry
Diagnostic Equipment
Other Industries
Decision/Risk Analysis
Vertical(s)
Digital Health, Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • One Broadway, 14th Floor
  • Cambridge, MA 02142
  • United States

UltraSight Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

UltraSight Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series B) 24-Aug-2026 $23.9M Completed Generating Revenue
9. Accelerator/Incubator 27-May-2026 Completed Generating Revenue
8. Accelerator/Incubator 16-Apr-2026 Completed Generating Revenue
7. Accelerator/Incubator 17-Oct-2025 Completed Generating Revenue
6. Accelerator/Incubator 12-Mar-2025 Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Early Stage VC (Series B) 11-May-2021 Completed Clinical Trials - General
3. Grant 16-Oct-2020 Completed Clinical Trials - General
2. Accelerator/Incubator 01-Jan-2020 $2M Completed Clinical Trials - General
1. Early Stage VC (Series A) 19-Mar-2019 $2M $2M Completed Clinical Trials - General
To view UltraSight’s complete valuation and funding history, request access »

UltraSight Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B3
Series B2
Series B1
Series B 7,868,713 $0.000100 5% $2.22 $2.22 1x $0.48 14.43%
Series A 2,711,116 $0.000100 5% $0.83 $0.83 1x $0.28 3.18%
To view UltraSight’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

UltraSight Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

UltraSight Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20100179853-A1 System and method for project and resource management Inactive 13-Jan-2009

UltraSight Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

UltraSight Investors (22)

Investor Name Investor Type Holding Investor Since Participating Rounds
ALIVE Israel Healthtech Fund Venture Capital Minority
Connecticut Innovations Venture Capital Minority
Deep Insight (Herzliya) Venture Capital Minority
eHealth Ventures (Israel) Venture Capital Minority
Iron Nation Fund Venture Capital Minority
You’re viewing 5 of 22 investors. Get the full list »

UltraSight Investments (1)

UltraSight’s most recent deal was a Joint Venture with Selvas InVision. The deal was made on 14-Feb-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Selvas InVision 14-Feb-2024 Joint Venture Diagnostic Equipment
To view UltraSight’s complete investments history, request access »

Ready to get started?

Request a free trial

UltraSight FAQs

  • When was UltraSight founded?

    UltraSight was founded in 2018.

  • Where is UltraSight headquartered?

    UltraSight is headquartered in Cambridge, MA.

  • What is the size of UltraSight?

    UltraSight has 25 total employees.

  • What industry is UltraSight in?

    UltraSight’s primary industry is Diagnostic Equipment.

  • Is UltraSight a private or public company?

    UltraSight is a Private company.

  • What is the current valuation of UltraSight?

    The current valuation of UltraSight is .

  • What is UltraSight’s current revenue?

    The current revenue for UltraSight is .

  • How much funding has UltraSight raised over time?

    UltraSight has raised $38.9M.

  • Who are UltraSight’s investors?

    ALIVE Israel Healthtech Fund, Connecticut Innovations, Deep Insight (Herzliya), eHealth Ventures (Israel), and Iron Nation Fund are 5 of 22 investors who have invested in UltraSight.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process